Aisha Vadhariya

421 total citations
32 papers, 279 citations indexed

About

Aisha Vadhariya is a scholar working on Epidemiology, Rheumatology and Family Practice. According to data from OpenAlex, Aisha Vadhariya has authored 32 papers receiving a total of 279 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Epidemiology, 8 papers in Rheumatology and 7 papers in Family Practice. Recurrent topics in Aisha Vadhariya's work include Medication Adherence and Compliance (7 papers), Spondyloarthritis Studies and Treatments (6 papers) and Inflammatory Bowel Disease (6 papers). Aisha Vadhariya is often cited by papers focused on Medication Adherence and Compliance (7 papers), Spondyloarthritis Studies and Treatments (6 papers) and Inflammatory Bowel Disease (6 papers). Aisha Vadhariya collaborates with scholars based in United States, United Kingdom and Canada. Aisha Vadhariya's co-authors include Michael L. Johnson, Susan Abughosh, Holly M. Holmes, Manvi Sharma, Zachary A. Marcum, Omar Serna, Ekere James Essien, Polly Niravath, Meghana V. Trivedi and Marc L. Fleming and has published in prestigious journals such as The American Journal of Gastroenterology, Journal of the American Academy of Dermatology and Medicine.

In The Last Decade

Aisha Vadhariya

28 papers receiving 260 citations

Peers

Aisha Vadhariya
Lisa A. Fulchino United States
Rosa Romero‐Jiménez Spain
Karen Van Nuys United States
Matthew H Rim United States
Nancy M. Kornegay United States
Tomáš Tesař Slovakia
Benyam Muluneh United States
Alberto Costantini Italy
Eve M. Segal United States
Mirta Millares United States
Lisa A. Fulchino United States
Aisha Vadhariya
Citations per year, relative to Aisha Vadhariya Aisha Vadhariya (= 1×) peers Lisa A. Fulchino

Countries citing papers authored by Aisha Vadhariya

Since Specialization
Citations

This map shows the geographic impact of Aisha Vadhariya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aisha Vadhariya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aisha Vadhariya more than expected).

Fields of papers citing papers by Aisha Vadhariya

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aisha Vadhariya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aisha Vadhariya. The network helps show where Aisha Vadhariya may publish in the future.

Co-authorship network of co-authors of Aisha Vadhariya

This figure shows the co-authorship network connecting the top 25 collaborators of Aisha Vadhariya. A scholar is included among the top collaborators of Aisha Vadhariya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aisha Vadhariya. Aisha Vadhariya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Lee, Scott D., Séverine Vermeire, Ryan C. Ungaro, et al.. (2025). Mirikizumab Improves Quality of Life and Work Productivity in Patients with Moderately to Severely Active Crohn's Disease: Results from the Phase 3 VIVID-1 Study. The American Journal of Gastroenterology. 120(8). 1809–1819.
3.
Jairath, Vipul, Geert D’Haens, Bruce E. Sands, et al.. (2025). Bowel Urgency in Crohn’s Disease: Effects of Mirikizumab in a Randomized Controlled Phase 3 Study. Clinical Gastroenterology and Hepatology. 24(2). 463–473.e5.
4.
Vadhariya, Aisha, et al.. (2025). REAL-WORLD DOSING PATTERNS OF BIOLOGICS IN CROHN’S DISEASE AND ULCERATIVE COLITIS: A RETROSPECTIVE OBSERVATIONAL STUDY. Inflammatory Bowel Diseases. 31(Supplement_1). S8–S8.
5.
Regueiro, Miguel, Aisha Vadhariya, Frédérick Durand, et al.. (2024). Psychometric evaluation of the Functional Assessment of chronic illness therapy–fatigue (FACIT-Fatigue) in adults with moderately to severely active Crohn’s disease. Quality of Life Research. 34(2). 509–521. 2 indexed citations
6.
Tillett, William, et al.. (2024). Filling the “GAP” in Real-World Assessment of Psoriatic Arthritis Disease Activity: Performance Characteristics of a Global/Pain Composite Endpoint. Rheumatology and Therapy. 11(5). 1101–1114. 1 indexed citations
7.
Rohekar, Sherry, Aisha Vadhariya, Sarah J. Ross, et al.. (2024). Real‐World Treatment Patterns, Clinical Outcomes, and Symptom Burden in Patients With Psoriatic Arthritis Prescribed Ixekizumab in the United States. ACR Open Rheumatology. 6(7). 440–449. 1 indexed citations
8.
Mease, Philip J., Soumya M. Reddy, Sarah J. Ross, et al.. (2024). Evaluating the efficacy of biologics with and without methotrexate in the treatment of psoriatic arthritis: a network meta-analysis. RMD Open. 10(1). e003423–e003423. 6 indexed citations
9.
10.
Dubinsky, Marla, Aisha Vadhariya, Frédérick Durand, et al.. (2024). The Urgency Numeric Rating Scale: Psychometric Evaluation in Adults with Crohn’s Disease. Advances in Therapy. 42(2). 1044–1060. 2 indexed citations
11.
Brunner, Hermine I., Aisha Vadhariya, Christina Dickson, et al.. (2023). Treatment patterns in paediatric and adult patients with SLE: a retrospective claims database study in the USA. Lupus Science & Medicine. 10(2). e000817–e000817. 10 indexed citations
12.
Tillett, William, Julie Birt, Yoojin Jung, et al.. (2023). Changes in musculoskeletal disease activity and patient-reported outcomes in patients with psoriatic arthritis treated with ixekizumab: results from a real-world US cohort. Frontiers in Medicine. 10. 1184028–1184028. 5 indexed citations
13.
Vadhariya, Aisha, et al.. (2021). Impact of a motivational interviewing intervention targeting statins on adherence to concurrent hypertension or diabetes medications. Patient Education and Counseling. 104(7). 1756–1764. 6 indexed citations
14.
Vadhariya, Aisha, et al.. (2021). Evaluating perceptions of social determinants of health and Part D star performance of Medicare Advantage-contracted primary care providers serving a South Texas market. Journal of Managed Care & Specialty Pharmacy. 27(5). 544–553. 4 indexed citations
15.
Sharma, Manvi, Aisha Vadhariya, Suma Gopinathan, et al.. (2019). Clinical Outcomes Associated with Drug–Drug Interactions of Oral Chemotherapeutic Agents: A Comprehensive Evidence-Based Literature Review. Drugs & Aging. 36(4). 341–354. 26 indexed citations
16.
Shah, Anuj, et al.. (2019). The risk of varenicline-induced seizure among those who have attempted to quit smoking using pharmacotherapy. Epilepsy & Behavior. 97. 169–173. 3 indexed citations
17.
Vadhariya, Aisha, et al.. (2018). Interventions to improve endocrine therapy adherence in breast cancer survivors: what is the evidence?. Journal of Cancer Survivorship. 12(3). 348–356. 50 indexed citations
18.
Chen, Hua, Patrick S. Bordnick, Ekere James Essien, et al.. (2018). Comparative Effectiveness of Smoking Cessation Medications among Schizophrenic Smokers. Trends journal of sciences research. 3(3). 104–115. 2 indexed citations
19.
Sharma, Manvi, Aisha Vadhariya, Michael L. Johnson, Zachary A. Marcum, & Holly M. Holmes. (2018). Association between industry payments and prescribing costly medications: an observational study using open payments and medicare part D data. BMC Health Services Research. 18(1). 236–236. 48 indexed citations
20.
Vadhariya, Aisha & Shubhada Sansgiry. (2015). Use of Health belief model to understand Knowledge, Attitudes And Behaviors of People Towards The Ebola outbreak. Value in Health. 18(3). A241–A241. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lisa A. Fulchino Breakdown of academic impact, for papers by Rosa Romero‐Jiménez Breakdown of academic impact, for papers by Karen Van Nuys Breakdown of academic impact, for papers by Matthew H Rim Breakdown of academic impact, for papers by Nancy M. Kornegay Breakdown of academic impact, for papers by Tomáš Tesař Breakdown of academic impact, for papers by Benyam Muluneh Breakdown of academic impact, for papers by Alberto Costantini Breakdown of academic impact, for papers by Eve M. Segal Breakdown of academic impact, for papers by Mirta Millares
Rankless by CCL
2026